Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
大麻股在全球醫療大麻市場出現20%的年增長，預計將受益於國際大麻監管改革。
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced its financial and operational results Thursday for the fourth quarter and fiscal year 2024.
Aurora Cannabis公司（納斯達克：ACB）（tsx：ACB）宣佈了其2024財年第四季度和財年財務和運營結果。
The Alberta-based cannabis giant noted the year-over-year comparison quarter for the fourth quarter of 2024 ending March 31, 2024, is the third quarter of fiscal 2023 ending March 31, 2023, as the fiscal year 2023 consisted of three quarters.
這家總部位於阿爾伯塔省的大麻巨頭指出，截止於2024年3月31日的第四個季度與財政2023年3月31日結束的財政第三個季度進行了同比年度比較，因爲2023財年由三個季度組成。
The company reported a 5% year-over-year increase in revenue to CA$67.4 million ($49.1 million) in the fourth quarter.
公司報告了第四季度營業收入增長了5％，達到6740萬加元（4910萬美元）。
Global medical cannabis net revenue grew by 20% over the same period to CA$45.6 million. The increase in net revenue1 of $7.7 million was primarily due to higher sales...
全球醫用大麻淨收入同比增長20％，達到4560萬加元...
登入免費觀看全文
登入/註冊